CAFC Upholds PTAB Ruling for Corcept, Finding Teva Failed to Show a Reasonable Expectation of Success
CAFC Upholds PTAB Ruling for Corcept, Finding Teva Failed to Show a Reasonable Expectation of Success
Briefly

"Teva was required to prove a reasonable expectation of success in achieving the specific invention claimed, a 600 mg dosage."

[

]

[

...

]

CAFC Upholds PTAB Ruling for Corcept, Finding Teva Failed to Show a Reasonable Expectation of SuccessCAFC Upholds PTAB Ruling for Corcept, Finding Teva Failed to Show a Reasonable Expectation of Success Briefly